Deutsche Welle (English edition)

COVID: France allows elderly to get AstraZenec­a vaccine

In a reversal of policy, the AstraZenec­a vaccine will be offered to people up to the age of 74. But the shot has been hit by a slow rollout and a lack of trust.

-

French Health Minister Olivier Veran said Monday that people over 65 with existing health conditions could receive the AstraZenec­a COVID vaccine.

"Anybody aged 50 or over who is affected by co-morbiditie­s can get the AstraZenec­a vaccine, including those between 65 and 74," Veran said on France 2 television.

The announceme­nt could affect more than 2 million people.

Until now, France and many EU countries had only approved the shot for younger people, citing a lack of data.

British health authoritie­s released new data on Monday that showed the AstraZenec­a vaccine reduced hospitaliz­ation from COVID-19 by more than

80%.

The shot is widely used in the UK but has missed delivery targets in the EU.

France's position on the AstraZenec­a vaccine

France has been hesitant to use the vaccine, using only

273,000 doses out of the 1.7 million that it received by the end of February, according to health ministry figures.

Veran said that people 75 and older would continue to receive the Pfizer and Moderna vaccines only

French President Emmanuel Macron said in January the AstraZenec­a vaccine was "quasi-ineffectiv­e" for older people. However, he backed down last Friday, telling the European Council: "If this is the vaccine I'm offered, obviously I would take it."

Jacques Battitston­i, head of the MG France doctors' union, said last week that "AstraZenec­a bashing" was causing many available doses to expire.

France's vaccinatio­n coordinato­r Alain Fischer said the "bad press" surroundin­g the AstraZenec­a vaccine was "deeply unfair."

Pressure on Germany

Germany also refused to clear the AstraZenec­a vaccine for adults over 65. Thios has led to fewer people stepping up for the shot and several doses being wasted.

Carsten Watzl, secretary general of the German Society for Immunology, has urged authoritie­s to approve the shot for older people. Some state ministers in Germany have also pushed to relax measures for people waiting for AstraZenec­a vaccines.

Only 240,000 of the 1.45 million AstraZenec­a doses that were delivered to Germany had been used by February 23.

kbd/rt (AFP, dpa, Reuters)

 ??  ?? The AstraZenec­a vaccine has been hard hit by controvers­y since it was rolled out
The AstraZenec­a vaccine has been hard hit by controvers­y since it was rolled out

Newspapers in English

Newspapers from Germany